Search Kailos website
Our Expedio™ Hereditary Cancer and Inspexion™ Pharmacogenetics tests are physician-directed genetic screenings that offer a cost-effective strategy designed to achieve optimized, personalized care for your patients.
Acquisition Positions healthŌme to Become the First Integrated Precision Health Management Company Dedicated Specifically to the Life Insurance Industry
Recent advances in DNA sequencing and analysis make it faster, easier and more affordable than ever before to screen a single patient for adverse mutations in a whole host of genes associated with an increased risk of developing cancer.
July 28, 2021
When we think about the human genome, or the instructions used to create the human body that are stored as DNA in virtually every cell, we often think of a static, unchanging instruction manual.
June 21, 2021
Genetic variation between races can contribute to differences in cancer incidence and survival rates, but research has consistently shown higher cancer rates and poorer outcomes for black people for the majority of cancer types.1
June 17, 2021
The discovery of the BRCA genes, BRCA1 and BRCA2, and their association with hereditary breast cancer revolutionized the field of cancer biology and set the stage for future breakthroughs in cancer genetics.